Executive Incentives Through Stock Acquisition Rights
First written in FY2017-Q1. 23 of 24 entries say "Advanced", first in FY2017. Latest entry: FY2027-H1.
- FY2027-H1AdvancedAnnual report
「Resolution date 14 May 2026 Category and number of eligible persons 4 company directors Number of stock acquisition rights 52 Class, terms and number of shares underlying the stock acquisition rights Common shares 5,200 Exercise period for the stock acquisition rights From 16 July 2026 to 15 July 2041」
For the resolution dated 14 May 2026, the company granted 52 stock acquisition rights to 4 directors, covering 5,200 shares, and set the exercise period through 15 July 2041. - FY2026AdvancedAnnual report
「For the stock options approved on 15 May 2025, 5,300 shares have been exercised and 1,200 shares remain unexercised.」
Of the 6,500 stock acquisition rights for directors approved in May 2025, 5,300 shares were exercised and 1,200 shares remain unexercised. - FY2026-H1AdvancedAnnual report
「Resolution date 15 May 2025 Category and number of eligible recipients (people) Directors of the Company 4 Number of stock acquisition rights (units)* 65 Class, terms and number of shares underlying the stock acquisition rights (shares)* Common shares 6,500 Exercise period for the stock acquisition rights* From 16 July 2025 to 15 July 2040」
As part of the resolutions passed in May 2025, 6,500 stock acquisition rights were granted to 4 directors, with an exercise period extending through July 2040. - FY2025AdvancedAnnual report
「Regarding the stock options approved on 10 April 2024, 6,500 shares were exercised, and 1,700 shares remained unexercised.」
Regarding the stock acquisition rights for directors granted under the April 2024 resolution, 6,500 of the 8,200 shares were exercised, leaving 1,700 shares unexercised. - FY2025-Q1AdvancedAnnual report
「Date of resolution 10 April 2024 Category and number of grantees (people) 4 company directors Number of stock acquisition rights (units) (Note) 82 Class, description and number of shares underlying the stock acquisition rights (shares) (Note) Common shares, 8,200 Exercise period (Note) From 1 June 2024 to 31 May 2039」
For the April 2024 resolution, the company granted 82 stock acquisition rights to 4 directors, representing 8,200 underlying shares, with an exercise period through May 2039. - FY2024-Q1AdvancedAnnual report
「Date of resolution 12 April 2023 Category and number of grantees (people) 4 company directors Number of stock acquisition rights (units) (Note) 63 Class, description and number of shares underlying the stock acquisition rights (shares) (Note) Common shares, 6,300 Exercise period (Note) From 1 June 2023 to 31 May 2038」
For the April 2023 resolution, the company granted 63 stock acquisition rights to 4 directors, representing 6,300 underlying shares, with an exercise period through 31 May 2038. - FY2023AdvancedAnnual report
「Regarding the stock options approved on 8 April 2022, 7,400 common shares were granted, 3,300 shares were exercised, and 4,100 shares remained unexercised.」
Regarding the stock acquisition rights for directors approved in April 2022, 3,300 of the 7,400 shares granted were exercised, leaving 4,100 shares unexercised at fiscal year-end. - FY2023-Q1AdvancedAnnual report
「Date of resolution 8 April 2022 Category and number of grantees (people) 5 company directors Number of stock acquisition rights (units) (Note) 74 Class, description and number of shares underlying the stock acquisition rights (shares) (Note) Common shares, 7,400 Exercise period (Note) From 2 June 2022 to 1 June 2037」
For the April 2022 resolution, the company granted 74 stock acquisition rights to 5 directors, representing 7,400 underlying shares, with an exercise period through June 2037. - FY2022AdvancedAnnual report
「Regarding the stock options approved on 9 April 2021, 7,400 shares were exercised, and the unexercised balance was nil.」
The 26th Series Stock Options granted in April 2021 were exercised for 7,400 shares, leaving no unexercised balance at fiscal year-end. - FY2022-Q1AdvancedAnnual report
「Date of resolution 9 April 2021 Category and number of grantees (people) 5 company directors Number of stock acquisition rights (units) (Note) 74 Class, description and number of shares underlying the stock acquisition rights (shares) (Note) Common shares, 7,400 Exercise period (Note) From 7 June 2021 to 6 June 2036」
For the April 2021 resolution, the company granted 74 stock acquisition rights to 5 directors, representing 7,400 underlying shares, with an exercise period through June 2036. - FY2021AdvancedAnnual report
「Twenty-Fifth Series Stock Options: 4 company directors; common shares, 6,300; exercise period, from 1 June 2020 to 31 May 2035」
For the April 2020 resolution, the company granted 6,300 stock acquisition rights to 4 directors, of which 1,100 shares were exercised during the fiscal year. - FY2021-Q1AdvancedAnnual report
「Date of resolution 10 April 2020 Category and number of grantees (people) 4 company directors Number of stock acquisition rights (units) (Note) 63 Class, description and number of shares underlying the stock acquisition rights (shares) (Note) Common shares, 6,300 Exercise period (Note) From 1 June 2020 to 31 May 2035」
For the resolution dated 10 April 2020, the company granted 63 stock acquisition rights to 4 directors, representing 6,300 underlying shares, with an exercise period through 31 May 2035. - FY2020-Q3AdvancedAnnual report
「Twenty-Fourth Series Stock Acquisition Rights Category and number of grantees (people) 2 company directors 2 former directors of Maxvalu Chubu Co., Ltd. Number of stock acquisition rights (units) (Note) 124 Class, description and number of shares underlying the stock acquisition rights (shares) (Note) Common shares, 7,316 Exercise period (Note) From 1 September 2019 to 9 June 2034」
In connection with the business integration, the company disclosed stock acquisition rights from the Thirteenth through Twenty-Fourth Series for former directors of Maxvalu Chubu and the company's directors, with exercise periods extending through 2034 at the longest. - FY2020-Q1AdvancedAnnual report
「Twelfth Series Stock Acquisition Rights: date of resolution, 10 April 2019; category and number of grantees (people), 8 company directors; number of stock acquisition rights (units), 95; class, description and number of shares underlying the stock acquisition rights (shares), common shares, 9,500; exercise period, from 7 June 2019 to 6 June 2034.」
The company granted 95 Twelfth Series Stock Acquisition Rights to 8 executives, representing 9,500 underlying shares, with an exercise period through 6 June 2034. - FY2019AdvancedAnnual report
「Regarding the Eleventh Series Stock Options, 11,700 shares were granted during the current consolidated fiscal year, 1,700 shares were exercised, and 10,000 shares remained unexercised.」
Regarding the Eleventh Series Stock Acquisition Rights for executives, 1,700 of the 11,700 shares granted were exercised, leaving 10,000 shares unexercised. - FY2019-Q1AdvancedAnnual report
「Eleventh Series Stock Acquisition Rights Date of resolution 11 April 2018 Number of stock acquisition rights (units) 117 Number of shares underlying the stock acquisition rights (shares) 11,700 (Note 1) Exercise period From 1 June 2018 To 31 May 2033」
The company issued 117 Eleventh Series Stock Acquisition Rights for executives, representing 11,700 underlying shares, with an exercise period from June 2018 through May 2033. - FY2018AdvancedAnnual report
「Regarding the stock options approved by the Board of Directors on 12 April 2017, 12,500 shares were granted during the current consolidated fiscal year, 4,500 shares were exercised, and 8,000 shares remained unexercised.」
Regarding the Tenth Series Stock Acquisition Rights for executives, 4,500 of the 12,500 shares granted were exercised, leaving 8,000 shares unexercised. - FY2018-Q1AdvancedAnnual report
「Tenth Series Stock Acquisition Rights Date of resolution 12 April 2017 Number of stock acquisition rights (units) 125 Number of shares underlying the stock acquisition rights (shares) 12,500 Exercise period From 1 June 2017 To 31 May 2032」
The company issued 125 Tenth Series Stock Acquisition Rights for executives, representing 12,500 underlying shares, with an exercise period through 31 May 2032. - FY2017AdvancedAnnual report
「Regarding the stock options approved by the Board of Directors on 13 April 2016, 13,800 shares were granted during the current consolidated fiscal year, 9,900 shares were exercised, and 3,900 shares remained unexercised.」
Regarding the stock acquisition rights granted to executives, 9,900 of the 13,800 shares granted in 2016 were exercised, and 3,900 shares remained unexercised at fiscal year-end. - FY2017-Q1First statedAnnual report
「The stock acquisition rights issued during the current first quarter accounting period were as follows. Ninth Series Stock Acquisition Rights: number of stock acquisition rights (units), 138; number of shares underlying the stock acquisition rights (shares), 13,800; exercise period: from 2 June 2016 to 2 June 2031.」
The company issued 138 Ninth Series Stock Acquisition Rights to be held by directors, representing 13,800 underlying shares, with a long exercise period.